<DOC>
	<DOCNO>NCT01325974</DOCNO>
	<brief_summary>Background : Antigen-detecting rapid diagnostic test ( RDTs ) malaria provide possibility parasite-based diagnosis area good quality microscopy achieve . P. falciparum test target histidine-rich protein ( HRP2 ) antigen generally sensitive test target Plasmodium lactate dehydrogenase ( pLDH ) antigen . However , HRP2 antigen eliminate bloodstream slowly pLDH antigen , HRP2-based test give positive result two week patient take effective treatment , pLDH test generally turn negative day . The use RDT positive result routine patient care therefore challenge interpretation whether result due last effect already treat infection new infection . The interpretation might also affect level malaria transmission area . Objective : The objective study estimate proportion positive test patient successfully treat malaria ( smear negative ) different time point time treatment , three rapid diagnostic test : SD Bioline Malaria Antigen P.f . ( catalogue number : 05FK50-02-4 ) , CareStart Malaria HRP2 ( Pf ) ( catalogue number : G0141 ) CareStart Malaria pLDH ( PAN ) ( catalogue number : G0111 ) . The study carry two setting know low high malaria transmission level order provide guidance interpretation RDT positive result depend intensity malaria transmission . Secondary objective measure sensitivity specificity malaria rapid test compare smear microscopy , estimate median time become negative test estimate proportion positive test median time become negative accord initial parasitaemia presence gametocyte .</brief_summary>
	<brief_title>Time Become Negative Three Rapid Diagnostic Tests Malaria</brief_title>
	<detailed_description>The study population patient 5 year age attend consultation service one health centre Mbarara municipality ( low transmission set ) one health centre Kazo sub-county ( high transmission set ) clinical diagnosis malaria confirm smear microscopy least one positive RDT . Patients general sign danger severe malaria take full course antimalarial treatment previous 2 week exclude . Written consent seek participant . A total 212 patient include set . The sample size base minimum accuracy 8 % around proportion 50 % positive RDTs 15 % added patient positive RDTs secondarily exclude analysis . A three-day artemether-lumefantrine give enrolled case treatment intake supervise . RDTs blood smear microscopy repeat day 2 , 3 , 5 , 7 , 14 , 21 , 28 , 35 42 inclusion RDTs become negative . Follow-up last long 42 day . The proportion 95 % confidence interval positive test among patient negative thick smear calculate day follow-up . Moreover investigator identify test regression model estimate number day require obtain 50 , 25 , 10 5 % probability false positive RDT result . Sensitivity , specificity , positive negative predictive value estimate RDT independently use result microscopy reference . The analysis perform use day 0 result patient enrol study .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<criteria>Inclusion Criteria ( sensitivity/specificity analysis ) : Age 5 year Clinical malaria define fever ( axillary temperature ≥ 37.5°C ) history fever previous 48 hour Weight ≥ 5 kg Informed consent give parent tutor Additional inclusion criterion ( time become negative analysis ) : Positive blood smear Plasmodium falciparum monoinfection day inclusion At least one RDT positive day inclusion High probability come followup visit Exclusion Criteria ( time become negative analysis ) : General sign danger severe malaria accord WHO criteria Treatment course antimalarial previous 2 week</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Malaria</keyword>
	<keyword>Plasmodium falciparum</keyword>
	<keyword>Diagnosis</keyword>
	<keyword>Rapid diagnostic test</keyword>
	<keyword>malaria transmission</keyword>
</DOC>